Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
- PMID: 35214741
- PMCID: PMC8880534
- DOI: 10.3390/vaccines10020283
Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
Abstract
The Omicron variant of concern (VOC), first detected in Italy at the end of November 2021, has since spread rapidly, despite high vaccine coverage in the Italian population, especially in healthcare workers (HCWs). This study describes an outbreak of SARS-CoV-2 Omicron infection in 15 booster-vaccinated HCWs. On 16 December 2021, two HCWs working in the same ward were infected with SARS-CoV-2. The Omicron VOC was suspected due to S gene target failure on molecular testing. Further investigation revealed that 15 (65%) of 23 HCWs attending a social gathering on 13 December were infected with Omicron, as shown by whole-genome sequencing, with a phylogenetic tree suggesting a common source of exposure. Five of these HCWs experienced mild symptoms. A patient with multiple chronic conditions hospitalized in the same ward was also infected by one of the HCWs involved in the outbreak. Despite being booster vaccinated, this patient required ICU treatment. Ten subjects achieved negativity in 10-19 days. The outbreak in booster-vaccinated subjects confirms the high transmissibility and immune evasion of the Omicron VOC. More stringent non-pharmaceutical interventions, administration of booster doses, and genomic surveillance are crucial long-term strategies to mitigate the consequences of the spread of the Omicron VOC.
Keywords: COVID-19 vaccine; Italy; SARS-CoV-2 Omicron variant; epidemiology; hospitalization; outbreak; surveillance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.Vaccines (Basel). 2022 Apr 24;10(5):674. doi: 10.3390/vaccines10050674. Vaccines (Basel). 2022. PMID: 35632430 Free PMC article.
-
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.Clin Microbiol Infect. 2021 Aug;27(8):1174.e1-1174.e4. doi: 10.1016/j.cmi.2021.05.007. Epub 2021 May 10. Clin Microbiol Infect. 2021. PMID: 33984489 Free PMC article.
-
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.Viruses. 2022 Nov 30;14(12):2688. doi: 10.3390/v14122688. Viruses. 2022. PMID: 36560692 Free PMC article.
-
Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019-8022. doi: 10.26355/eurrev_202112_27653. Eur Rev Med Pharmacol Sci. 2021. PMID: 34982466 Review.
-
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.Immune Netw. 2021 Dec 23;21(6):e38. doi: 10.4110/in.2021.21.e38. eCollection 2021 Dec. Immune Netw. 2021. PMID: 35036025 Free PMC article. Review.
Cited by
-
A Comparison Between Omicron and Earlier COVID-19 Variants' Disease Severity in the Milan Area, Italy.Front Epidemiol. 2022 Jun 28;2:891162. doi: 10.3389/fepid.2022.891162. eCollection 2022. Front Epidemiol. 2022. PMID: 38455311 Free PMC article.
-
VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern.Vaccines (Basel). 2022 Mar 12;10(3):435. doi: 10.3390/vaccines10030435. Vaccines (Basel). 2022. PMID: 35335067 Free PMC article.
-
Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review.J Cell Mol Med. 2023 Jun;27(11):1443-1464. doi: 10.1111/jcmm.17747. Epub 2023 May 18. J Cell Mol Med. 2023. PMID: 37203288 Free PMC article.
-
Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.Vaccines (Basel). 2022 Apr 24;10(5):674. doi: 10.3390/vaccines10050674. Vaccines (Basel). 2022. PMID: 35632430 Free PMC article.
-
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2.RSC Adv. 2023 Jan 26;13(6):3677-3687. doi: 10.1039/d2ra06834f. eCollection 2023 Jan 24. RSC Adv. 2023. PMID: 36756584 Free PMC article. Review.
References
-
- World Health Organization Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. [(accessed on 20 January 2022)]. Available online: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.....
-
- Network for Genomic Surveillance in South Africa NGS-SA: Updates, COVID-19 Analysis, Narratives, Reports. Durban: NGS-SA. 2021. [(accessed on 20 January 2022)]. Available online: https://www.ngs-sa.org/ngs-sa_updates_covid-19_analysis_narratives_repor....
-
- World Health Organization Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States. 2021. [(accessed on 20 January 2022)]. Available online: https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-....
-
- European Center for Disease Prevention and Control Rapid Increase of a SARS-CoV-2 Variant with Multiple Spike Protein Mutations Observed in the United Kingdom. Dec 20, 2020. [(accessed on 20 January 2022)]. Threat Assessment Brief. Available online: https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-....
-
- Rambaut A. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations—SARS-CoV-2 Coronavirus/nCoV-2019 Genomic Epidemiology, Virological. 2020. [(accessed on 30 January 2021)]. Available online: https://virological.org/t/preliminary-genomic-characterisation-of-an-eme....
LinkOut - more resources
Full Text Sources
Miscellaneous